MedTrace Logo

A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale)

NCT00885807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2011-06-20

No results posted yet for this study

Summary

The purpose of the study is to evaluate the psychometric validation of the Weiss Functional Impairment Rating Scale and the Weiss Symptom Record. It is hypothesized that the Weiss Functional Impairment Rating Scale has strong psychometric properties and good convergent validity with other measures of functioning and discriminant validity from symptoms and quality of life.

Conditions

  • Attention-Deficit/Hyperactivity Disorder

Sponsors & Collaborators

  • Eli Lilly and Company

    collaborator INDUSTRY

  • Purdue Pharma LP

    collaborator INDUSTRY

  • Shire

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Margaret D. Weiss, MD, Ph.D · University of British Columbia

  • Chistopher Gibbins, MD · BC Children's & Women's Hospital, Vancouver

  • Grant Iverson, MD · University of British Columbia

  • Brian Brooks, MD · BC Children's & Women's Hospital, Vancouver

  • Li Ying Lu, MD · BC Children's & Women's Hospital, Vancouver

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885807 on ClinicalTrials.gov